SkinTreat main objective is to realize the promise of customized remedy in the context of managing skin syndromes. The consortium intends to develop and validate nano-chemical and bio- technologies to achieve an accurate match between drugs, drug delivery vehicles, skin diseases and sub pathogenic skin conditions per individual. The project will lead to a new generation of pharmaceutical products, as well as consumer personalized service, which tailor a remedy per customer’s needs.

The development of personalized skin therapy protocols will involve non invasive methods as well as minimal invasive skin sampling, thus achieving an accurate diagnostics of skin condition, an extensive analysis of biological markers and the establishment of biological profiles corresponding to skin diseases and skin sub pathologic conditions. A bio-informatics data mining algorithm will be developed, together with multifunctional biomarker analysis software and a computerized decision support system, to enable a refined personalized diagnosis then to propose a personalized prescription. SKINTREAT concept will be evaluated by a pilot study.